EBD Group is part of the KNect365 of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Biotech Showcase 2015 EBD Group Demy-Colton
Share/Follow Us
Share this:
Follow this event:

Biotech Showcase™ Press Releases

News for Biotech Showcase™ 2017 will be available soon.

January 27, 2016Biotech Showcase™ 2016 reports record high attendance this year A record number of life science industry executives attended the eighth annual Biotech Showcase investor and networking conference, held January 11–13 in San Francisco. More than 2,500 executive-level delegates representing qualified private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives attended from 1,600...  more ►

December 22, 2016Biotech Showcase™ 2016 will be "home base" for investment community in San Francisco in January The eighth annual Biotech Showcase investor and networking conference will be held in San Francisco during the healthcare industry's busiest week of the year, January 11–13, 2016. The event acts as home base for innovative mid-small cap and private life sciences companies and the public, private and strategic investors eager to meet with them. Over 300 innovative comp...  more ►

November 10, 2015The 8th Annual Biotech Showcase will celebrate life sciences innovations in January 2016 amid the largest healthcare investor conference of the year The eighth annual Biotech Showcase investor and networking conference will be held January 11–13, 2016 in San Francisco, CA at Parc 55 San Francisco - A Hilton Hotel. The event is expected to bring together 2,100+ attendees representing the life science industry's most enterprising and pioneering biotech companies and major players in the drug development arena. The pr...  more ►

partnering360® Blog

July 14, 2016 Relationship-centric care: The power of digital health to transform and improve clinical trials We have all pondered the million-dollar question: In what way can healthcare and digital technology converge that will bring about lasting, clinically and economically impactful change to the effectiveness of therapeutics?   The answer might not lie exclusively in the physician-to-patient... more ►

June 30, 2016 Industry experts weigh in on Brexit situation and implications for the life science sector partnering360® recently spoke with Alasdair Stamps, Chairman of the Advisory Board and co-Founder of BioPartner UK, and Dr. Claire Skentelbery, Network Manager of Council of European BioRegions and researcher for Scientists for EU, to get their opinions on Brexit and its potential effects on life... more ►

June 21, 2016 Single-use technology means big cost savings for bioprocessing industry What does adoption of single-use technology mean for the bioprocessing industry?   The R&D and manufacturing of biologics and biosimilars is extremely expensive due to the amount of detail necessary to replicate and ensure validation of biosynthesis of living cells and their components. It... more ►

June 16, 2016 Promise of genome and cell therapies move closer to reality Stem cell technologies and adoptive immunotherapies are big buzzwords in the cell therapies world, with the promise of personalized therapies driving interest. Boston is a hotbed for cell and gene therapies potential. STATnews reported today that “several Boston-area hospitals have teamed up with... more ►

June 9, 2016 Surviving as a CMO   What are the key factors for survival as a CMO today? Nordic Life Science has spoken to some Nordic CMOs to get an insight into the current possibilities and challenges. Guest post by Anneli Hidalgo, Nordic Life Science   The pharmaceutical sector is undergoing some dramatic changes,... more ►

partnering360:Insight Latest headlines from partnering360:Insight

July 21, 2016 First-in-class “GlycoCAR” works for solid tumors and leukemia A new anticancer immunotherapy using chimeric antigen receptor (CAR) T-cells has been developed at University of Pennsylvania, targeting tumors as well as blood-borne cancer cells. more ►

June 21, 2016 AZ BioVenture Hub CEO says aim is an innovative ecosystem AstraZeneca’s BioVentureHub CEO explains the exchange's vision to generate a climate of open innovation to help grow and nurture the Scandinavian life science ecosystem. more ►

June 21, 2016 Sixth Element Capital outlines healthcare investment strategy Sixth Element Capital's managing partner explains private UK-based group's healthcare investment thinking. more ►

June 20, 2016 RMI says it has USD 200 million already under management The RusnanoMedInvest fund was set up four years ago and has USD 200 million under management in a ten-year closed end fund financed by Russian institutional investors, with 17 separate investments so far. more ►

June 20, 2016 Achelous Partners is built on knowing both life sciences and finance sectors The European Representative of Achelous Partners says the investment bank's proven strategy and strengths are built on parallel knowledge of the life sciences and financial sectors and outlines recent M&A examples. more ►

Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use